Real-time enrollment status for this nausea and vomiting clinical trial
Current Status
Completed
Checked: March 2, 2026 at 10:33 AM UTC
| NCT Number | NCT06804603 |
| Recruiting Status | Completed |
| Condition | Nausea and Vomiting |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Vanda Pharmaceuticals |
| Last Updated on CT.gov | November 12, 2025 (Nov 12, 2025) |
As of March 2, 2026: Clinical trial NCT06804603 is currently completed participants. This clinical trial study for nausea and vomiting is not currently accepting new participants at 3 locations across the United States. The study is sponsored by Vanda Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06804603 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06804603 was last updated Nov 12, 2025 (November 12, 2025). HelloStudys verifies this status automatically.